Published online by Cambridge University Press: 16 April 2020
This paper discusses the need for a health economics perspective and some of the central methodological issues raised by economic appraisals, including cost-effectiveness and cost-utility analyses. It illustrates how cost-effectiveness studies can inform policy and practice decisions concerning the treatment of schizophrenia, focusing on five generic evaluation questions commonly raised. Examples are drawn from recent and current UK research.
This paper is lodged as Personal Social Services Research Unit Discussion Paper 1063 and Centre for the Economics of Mental Health Working Paper 025. Parts of this paper are adapted from Knapp (1994).
Comments
No Comments have been published for this article.